GLP-1 CollectivePolicy Tracker · Patient Lens · July 6, 2026
Novo Nordisk sued over what it told patients Ozempic can do
The claims at the center of the case could shape how every GLP-1 maker is allowed to advertise these drugs.
1 development affecting GLP-1 access were tracked on Sunday, July 5, 2026, across 1 category. Each entry links to the full record.
## Courts and enforcement
**[Novo Nordisk faces lawsuit over GLP-1 marketing claims](/lawsuits/cl-73580141)**.
By Amanda Bonello
Originally published by Patient Lens
on GLP-1 Laws, operated by GLP-1 Studio LLC — a for-profit company founded by
the Collective's Executive Director. Republished here in full, with permission,
at no cost. The Collective pays nothing for it and receives no payment for
publishing it. How this works.